Whitehawk Therapeutics (WHWK) Assets Average (2011 - 2026)
Whitehawk Therapeutics (WHWK) reported Assets Average of $139.0 million for Q1 2026, down 8.63% year-over-year from $152.2 million in Q1 2025, and down 12.52% on a QoQ basis from $158.9 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 16 years of Assets Average data on file, last reported at $139.0 million in Q1 2026.
- Quarterly Assets Average fell 8.63% year-over-year to $139.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139.0 million (down 8.63% YoY) and the FY2025 annual result came in at $110.6 million, up 9.08% from the prior year.
- Assets Average slipped to $139.0 million in Q1 2026 per WHWK's latest filing, from $158.9 million in the prior quarter.
- Across five years, Assets Average topped out at $207.4 million in Q2 2025 and bottomed at $78.0 million in Q4 2024.
- The 5-year median for Assets Average is $150.1 million (2022), against an average of $146.3 million.
- The widest annual swing landed in 2022, when Assets Average jumped 400.5%; it then tumbled 42.66% in 2024.
- Tracing WHWK's Assets Average over 5 years: stood at $189.2 million in 2022, then slipped by 28.09% to $136.0 million in 2023, then slumped by 42.66% to $78.0 million in 2024, then soared by 103.73% to $158.9 million in 2025, then dropped by 12.52% to $139.0 million in 2026.
- Per Business Quant, the three latest WHWK Assets Average figures stand at $139.0 million (Q1 2026), $158.9 million (Q4 2025), and $173.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 139.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.03 Mn |
| Dec 31, 2025 | 158.92 Mn |
| Sep 30, 2025 | 173.92 Mn |
| Jun 30, 2025 | 207.41 Mn |
| Mar 31, 2025 | 152.16 Mn |
| Dec 31, 2024 | 78.01 Mn |
| Sep 30, 2024 | 93.66 Mn |
| Jun 30, 2024 | 106.35 Mn |
| Mar 31, 2024 | 121.75 Mn |
| Dec 31, 2023 | 136.04 Mn |
| Sep 30, 2023 | 145.44 Mn |
| Jun 30, 2023 | 160.94 Mn |
| Mar 31, 2023 | 177.45 Mn |
| Dec 31, 2022 | 189.17 Mn |
| Sep 30, 2022 | 161.37 Mn |
| Jun 30, 2022 | 135.48 Mn |
| Mar 31, 2022 | 150.11 Mn |
| Dec 31, 2021 | 163.34 Mn |
| Sep 30, 2021 | 103.10 Mn |
| Jun 30, 2021 | 39.29 Mn |
| Mar 31, 2021 | 29.99 Mn |
| Dec 31, 2020 | 34.33 Mn |
| Sep 30, 2020 | 47.77 Mn |
| Jun 30, 2020 | 40.71 Mn |
| Mar 31, 2020 | 37.82 Mn |
| Dec 31, 2019 | 42.74 Mn |
| Sep 30, 2019 | 47.58 Mn |
| Jun 30, 2019 | 52.33 Mn |
| Mar 31, 2019 | 59.59 Mn |
| Dec 31, 2018 | 67.14 Mn |
| Sep 30, 2018 | 69.85 Mn |
| Jun 30, 2018 | 42.14 Mn |
| Mar 31, 2018 | 17.88 Mn |
| Dec 31, 2017 | 23.51 Mn |
| Sep 30, 2017 | 27.90 Mn |
| Jun 30, 2017 | 33.04 Mn |
| Mar 31, 2017 | 19.34 Mn |
| Dec 31, 2016 | 1.20 Mn |
| Sep 30, 2016 | 14,058.00 |
| Jun 30, 2016 | 16,754.00 |
| Mar 31, 2016 | 15,879.00 |
| Dec 31, 2015 | 12,399.50 |
| Sep 30, 2015 | 8,182.50 |
| Jun 30, 2015 | 16,691.00 |
| Mar 31, 2015 | 14,275.00 |
| Dec 31, 2014 | 11,565.50 |
| Sep 30, 2014 | 11,218.00 |
| Jun 30, 2014 | 5,538.00 |
| Mar 31, 2014 | 7,645.50 |
| Dec 31, 2013 | 11,726.50 |
| Sep 30, 2013 | 16,545.00 |
| Jun 30, 2013 | 11,125.50 |
| Mar 31, 2013 | 5,969.00 |
| Dec 31, 2012 | 9,686.50 |
| Sep 30, 2012 | 13,413.50 |
| Jun 30, 2012 | 19,892.00 |
| Mar 31, 2012 | 15,424.00 |
| Dec 31, 2011 | 8,565.00 |
| Sep 30, 2011 | 12,992.50 |